Checks immunity to HIV, hepatitis B and C, and four childhood infections, for occupational proof of immunity or for family planning and pregnancy contexts.
7 biomarkers as listed by Medichecks.
This test checks for markers of immunity or carrier status across seven areas: HIV antibodies and antigen, hepatitis B surface antibodies, hepatitis C antibodies, and IgG antibodies for measles, mumps, rubella and varicella (chickenpox). It is aimed at situations where you need documented proof of immunity, for example for certain jobs, or where you want to understand your carrier status ahead of starting a family or during pregnancy.
With 7 biomarkers this places in the 94th percentile among the immunity tests we track, so it is one of the deeper panels in its category. That depth comes at a significant premium, however: at £329 it costs 153% more than the £130.25 median for similarly sized immunity tests we track, by some margin the biggest gap between price and category median across this Medichecks range.
Collection requires a clinic visit, home nurse visit, or venous draw, with results back within 5 days. As with the rest of the range, every result is reviewed by a doctor, and Medichecks holds a 4.5 Trustpilot score from 2,477 reviews, UKAS ISO 15189 partner labs, and more than 25 years trading, though these trust signals apply across the whole catalogue rather than being specific to this test.
This suits people who specifically need documented proof of immunity, for example for occupational health requirements, or who want to check carrier status for HIV, hepatitis B and C, and common childhood infections ahead of pregnancy or family planning.
Given the price is more than double the category median for similarly sized immunity tests, it is worth checking whether a narrower test covering only the specific markers you need, for example just HIV, or just the childhood infections, would meet your requirement at a lower cost, since no directly comparable test is listed against this one.
You attend a Medichecks clinic, arrange a home nurse visit, or have a venous blood draw taken; there is no finger-prick at-home kit for this test. The lab checks for HIV, hepatitis B and C markers and IgG antibodies to measles, mumps, rubella and varicella, and a doctor reviews the results before you receive them, typically within 5 days.
This test checks immunity markers for HIV, hepatitis B and C, and four childhood infections (measles, mumps, rubella and varicella), aimed at occupational immunity checks or family planning and pregnancy contexts. At £329 it is priced well above the £130.25 median for similarly sized immunity tests we track, more than double in fact. The 7 markers themselves place it among the deeper tests in its category, but the price is the clear trade-off.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
7 biomarkers, placing it in the 94th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.5 from 2,477 reviews; accredited lab (UKAS ISO 15189 partner labs); doctor review as standard; trading 25+ years.
£329.00 against a median of £130.25 for the 19 similarly sized immunity tests we track (+153%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
